Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...

Lupin Limited announces the spin-off of its consumer healthcare division, LupinLife Consumer Healthcare Ltd., into a wholly ...

The move is part of Lupin's broader strategy to create a specialised consumer healthcare entity, particularly aimed at ...

Chouhan suggests buying Lupin at the current market price with a stop loss at Rs 1,940 and target price of Rs 2,035.

Pharmaceutical major Lupin Limited has announced the strategic spin-off of its consumer healthcare business, LupinLife ...

This is eligible for 180 days of generic drug exclusivity. The company will manufacture the product at its facility situated ...

Mumbai: Global pharma major Lupin Limited, has announced the strategic carve-out of its consumer healthcare business, ...

The product is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery.

Lupin launches independent consumer healthcare entity to focus on India's self-care market, led by Anil Kaushal.

Lupin has launched Prucalopride tablets in the US following USFDA approval. The bowel disorder treatment enters a $184 ...

Lupin receives US FDA approval for loteprednol etabonate ophthalmic gel: Our Bureau, Mumbai Wednesday, July 2, 2025, 11:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...